ConductScience.org, home

Paper12866987

When to Start Antiretroviral Therapy and What to Start With-- A European Perspective.

Wit FW and 1 other. Curr Infect Dis Rep, 2003. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. When to Start Antiretroviral Therapy and What to Start With-- A European Perspective. Papers, record 12866987. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12866987

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
When to Start Antiretroviral Therapy and What to Start With-- A European Perspective.
PubMed
Journal
Curr Infect Dis Rep
PubMed
Year
2003
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.06
iCite
Revised in PubMed
2022-08-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wit FWFerdinand W.N.M.
2Reiss PPeter

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111029005Immune control of HIV-1 after early treatment of acute infection.Nature2000https://conductscience.org/library/papers/11029005PubMed
210470083MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs.Nat Med1999https://conductscience.org/library/papers/10470083PubMed
312167680Antiretroviral-drug resistance among patients recently infected with HIV.N Engl J Med2002https://conductscience.org/library/papers/12167680PubMed
411231744Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.JAMA2001https://conductscience.org/library/papers/11231744PubMed
59107259British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Co-ordinating Committee.Lancet1997https://conductscience.org/library/papers/9107259PubMed
612700448A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.AIDS2003https://conductscience.org/library/papers/12700448PubMed
711534375[CBO guidelines 'Antiretroviral therapy in the Netherlands'].Ned Tijdschr Geneeskd2001https://conductscience.org/library/papers/11534375PubMed
810823790
High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy.
J Infect Dis2000https://conductscience.org/library/papers/10823790PubMed
910357379Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.AIDS1999https://conductscience.org/library/papers/10357379PubMed
1011722271Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.JAMA2001https://conductscience.org/library/papers/11722271PubMed
119544767A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.JAMA1998https://conductscience.org/library/papers/9544767PubMed
1210397562HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group.AIDS1999https://conductscience.org/library/papers/10397562PubMed
132460924Fidelity of HIV-1 reverse transcriptase.Science1988https://conductscience.org/library/papers/2460924PubMed
149619796Induction-maintenance antiretroviral therapy: proof of concept.AIDS1998https://conductscience.org/library/papers/9619796PubMed
159619798A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.AIDS1998https://conductscience.org/library/papers/9619798PubMed
169371822Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9371822PubMed
179660368Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.JAMA1998https://conductscience.org/library/papers/9660368PubMed
189662213Virological treatment failure of highly active antiretroviral therapy in an unselected cohort of HIV-infected patients.AIDS1998https://conductscience.org/library/papers/9662213PubMed
1910647802Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.JAMA2000https://conductscience.org/library/papers/10647802PubMed
209530544Antiretroviral therapy for HIV infection. A knowledge-based approach to drug selection and use.Drugs1998https://conductscience.org/library/papers/9530544PubMed

See all 67 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
22253667Readiness in HIV Treatment Adherence: A Matter of Confidence. An Exploratory Study.Open AIDS J2011https://conductscience.org/library/papers/22253667

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12866987

GET https://conductscience.org/api/papers/v1/12866987/references?page=2